Laura Lynne Stockton

Array ( [id] => 720321 [patent_doc_number] => 07049333 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => 'Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis' [patent_app_type] => utility [patent_app_number] => 10/448851 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18887 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 544 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049333.pdf [firstpage_image] =>[orig_patent_app_number] => 10448851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 892328 [patent_doc_number] => 07345078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-18 [patent_title] => 'NF-κB inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/449662 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 23 [patent_no_of_words] => 27048 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/345/07345078.pdf [firstpage_image] =>[orig_patent_app_number] => 10449662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7251808 [patent_doc_number] => 20050272936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Imidazolium cxcr3 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/516970 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5571 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272936.pdf [firstpage_image] =>[orig_patent_app_number] => 10516970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664627 [patent_doc_number] => 20030203953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Repinotan kit' [patent_app_type] => new [patent_app_number] => 10/444820 [patent_app_country] => US [patent_app_date] => 2003-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4589 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203953.pdf [firstpage_image] =>[orig_patent_app_number] => 10444820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643343 [patent_doc_number] => 20060281798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Methods of using thiazolidinedithione derivatives' [patent_app_type] => utility [patent_app_number] => 10/515087 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20392 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281798.pdf [firstpage_image] =>[orig_patent_app_number] => 10515087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7605160 [patent_doc_number] => 07115769 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-03 [patent_title] => 'Synthesis of 2-alkylcysteine via phase transfer catalysis' [patent_app_type] => utility [patent_app_number] => 10/438757 [patent_app_country] => US [patent_app_date] => 2003-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6488 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115769.pdf [firstpage_image] =>[orig_patent_app_number] => 10438757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7387048 [patent_doc_number] => 20040082639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders' [patent_app_type] => new [patent_app_number] => 10/438152 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 93216 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 44 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082639.pdf [firstpage_image] =>[orig_patent_app_number] => 10438152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1113172 [patent_doc_number] => 06803381 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-12 [patent_title] => 'Carbamic acid derivatives' [patent_app_type] => B1 [patent_app_number] => 10/438361 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8929 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/803/06803381.pdf [firstpage_image] =>[orig_patent_app_number] => 10438361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6926551 [patent_doc_number] => 20050239808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur' [patent_app_type] => utility [patent_app_number] => 10/514015 [patent_app_country] => US [patent_app_date] => 2003-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12143 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239808.pdf [firstpage_image] =>[orig_patent_app_number] => 10514015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 741688 [patent_doc_number] => 07030144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-18 [patent_title] => 'Substituted imidazole derivatives: GABAA receptor ligands' [patent_app_type] => utility [patent_app_number] => 10/429056 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15578 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/030/07030144.pdf [firstpage_image] =>[orig_patent_app_number] => 10429056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7402160 [patent_doc_number] => 20040019093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them' [patent_app_type] => new [patent_app_number] => 10/425210 [patent_app_country] => US [patent_app_date] => 2003-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4507 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019093.pdf [firstpage_image] =>[orig_patent_app_number] => 10425210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470031 [patent_doc_number] => 20040102502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Preventing/remedies for portal hypertension' [patent_app_type] => new [patent_app_number] => 10/415130 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14293 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102502.pdf [firstpage_image] =>[orig_patent_app_number] => 10415130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678929 [patent_doc_number] => 20030229070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonist and alpha-1-blocking action' [patent_app_type] => new [patent_app_number] => 10/421929 [patent_app_country] => US [patent_app_date] => 2003-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13387 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229070.pdf [firstpage_image] =>[orig_patent_app_number] => 10421929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678988 [patent_doc_number] => 20030229129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Preparations for topical administration of substances having antiandrogenic activity' [patent_app_type] => new [patent_app_number] => 10/422280 [patent_app_country] => US [patent_app_date] => 2003-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4696 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229129.pdf [firstpage_image] =>[orig_patent_app_number] => 10422280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1166769 [patent_doc_number] => 06756395 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-29 [patent_title] => 'Imidazolinyimethyl aralklsulfonamides' [patent_app_type] => B2 [patent_app_number] => 10/421119 [patent_app_country] => US [patent_app_date] => 2003-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17519 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/756/06756395.pdf [firstpage_image] =>[orig_patent_app_number] => 10421119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770640 [patent_doc_number] => 20030216580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Preparation of Isoxazolin-3-Ylacylbenzene' [patent_app_type] => new [patent_app_number] => 10/417083 [patent_app_country] => US [patent_app_date] => 2003-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14647 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216580.pdf [firstpage_image] =>[orig_patent_app_number] => 10417083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281394 [patent_doc_number] => 20040063771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors' [patent_app_type] => new [patent_app_number] => 10/417340 [patent_app_country] => US [patent_app_date] => 2003-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28641 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063771.pdf [firstpage_image] =>[orig_patent_app_number] => 10417340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 494190 [patent_doc_number] => 07211594 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-01 [patent_title] => 'Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith' [patent_app_type] => utility [patent_app_number] => 10/414839 [patent_app_country] => US [patent_app_date] => 2003-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 136943 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211594.pdf [firstpage_image] =>[orig_patent_app_number] => 10414839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865794 [patent_doc_number] => 20030191320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Process for the preparation of bis-benzazolyl compounds' [patent_app_type] => new [patent_app_number] => 10/399312 [patent_app_country] => US [patent_app_date] => 2003-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2361 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191320.pdf [firstpage_image] =>[orig_patent_app_number] => 10399312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639849 [patent_doc_number] => 20030212067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Matrix metalloprotease inhibitors' [patent_app_type] => new [patent_app_number] => 10/418012 [patent_app_country] => US [patent_app_date] => 2003-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33241 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212067.pdf [firstpage_image] =>[orig_patent_app_number] => 10418012 [rel_patent_id] =>[rel_patent_doc_number] =>)